-
Presentation
Presentation
This curricular unit addresses the unique specificities of creating and managing technology-based companies within the life sciences sector, with a particular focus on biotechnology and the pharmaceutical industry. The course aims to provide essential knowledge about different business models and the dynamics of the biotechnology and pharmaceutical markets, analyzing global trends, regulatory challenges, and innovation strategies. The scope of the curricular unit includes the identification of business opportunities, risk assessment, intellectual property, financing, technology transfer, marketing strategies, and the commercialization of innovative biotechnology products. The main areas of intervention include: Development of innovative business projects in biotechnology; Valorization of R&D results through technology transfer strategies; Preparation and assessment of business plans for products and services.
-
Class from course
Class from course
-
Degree | Semesters | ECTS
Degree | Semesters | ECTS
Bachelor | Semestral | 5
-
Year | Nature | Language
Year | Nature | Language
3 | Mandatory | Português
-
Code
Code
ULHT2710-17411
-
Prerequisites and corequisites
Prerequisites and corequisites
Not applicable
-
Professional Internship
Professional Internship
Não
-
Syllabus
Syllabus
Models of Technology Companies and Organizational Structures Startups and Spin-offs Incubators and Accelerators Joint Ventures and Strategic Partnerships Biotechnology / Pharma Ecosystem Relationship between biotech companies and the pharmaceutical industry Complementarities and synergies between biotech and big pharma/bio-pharma Value chains and collaboration networks in the sector Role of universities and research centers Innovation in Life Sciences Product development processes Intellectual property management Emerging technologies and their impact on the sector Innovation strategies incremental vs. disruptive Financing and Investment Sources of capital Marketing and Commercialization Market entry strategies Development of innovative business models Regulation Regulatory environment in biotechnology and pharma
-
Objectives
Objectives
Enable students to distinguish between different business models in the sector—namely startups, spin-offs, and joint ventures—by understanding the advantages, limitations, and application contexts of each model. Students should be able to identify the strategic factors involved, such as scalability, funding needs, time to market, and operational risks. Provide an integrated view of the interactions and synergies between biotechnology companies, big pharma, universities, and research centers, highlighting how strategic collaborations, partnerships, and innovation networks enable competitive capacity and drive scientific advances. Teach students to apply innovation strategies using emerging technologies, focusing on the processes that transform research into marketable products and services. Prepare students to manage the regulatory and ethical challenges specific to biotechnology. Foster an entrepreneurial, critical, and innovative mindset.
-
Teaching methodologies and assessment
Teaching methodologies and assessment
A business plan will be prepared throughout the classes. A pitch will be prepared and will be presented in the current model of presentation to investors. This work will be presented to the class
-
References
References
Scientific papers related to the subject
-
Office Hours
Office Hours
-
Mobility
Mobility
No
